drugset / Trial / NCT04207593

The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia

NCT04207593

Phase 2 Completed 20 enrolled Heidelberg University
RandomizedCrossoverOpen-labelTreatment

Summary

Treatment of O2 naïve patients with PAH will be included in this investigator-initiated trial (IIT) to assess efficacy and safety of oxygen substitution. Nocturnal oxygen substitution improved the 6MWD compared to placebo in one clinical trial in PAH patients. Due to the positive results in the treatment of patients with PAH, the initiation of this proof-of-concept study is justified.

Timeline

Start
2019-04-01
Primary completion
2023-01-01
Completion
2023-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxygen Other / unclassified